Barbara Ingold Heppner

3.2k total citations
6 papers, 229 citations indexed

About

Barbara Ingold Heppner is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Barbara Ingold Heppner has authored 6 papers receiving a total of 229 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 4 papers in Pulmonary and Respiratory Medicine and 3 papers in Cancer Research. Recurrent topics in Barbara Ingold Heppner's work include Cancer Immunotherapy and Biomarkers (3 papers), HER2/EGFR in Cancer Research (2 papers) and Advanced Breast Cancer Therapies (2 papers). Barbara Ingold Heppner is often cited by papers focused on Cancer Immunotherapy and Biomarkers (3 papers), HER2/EGFR in Cancer Research (2 papers) and Advanced Breast Cancer Therapies (2 papers). Barbara Ingold Heppner collaborates with scholars based in Germany. Barbara Ingold Heppner's co-authors include Katharina Balschun, Christoph Röcken, Sandra Krüger, Jochen Haag, Thomas Becker, Carsten Denkert, Sibylle Loibl, Karsten E. Weber, Berit M. Pfitzner and Wolfgang Schmitt and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and British Journal of Cancer.

In The Last Decade

Barbara Ingold Heppner

6 papers receiving 228 citations

Peers

Barbara Ingold Heppner

ONCOL

PRM

CR

PFM

IMMUN

David Vicente Baz Spain

Vassilena Tsvetkova Italy

Ying Cheng China

Zhao-Li Tan China

Larry Leon United States

Denise Lau United States

David Riseberg United States

Takehiro Tozuka Japan

Riham Katkhuda United States

Miao Huang China

David Vicente Baz Spain

Barbara Ingold Heppner

173 ×0.8

ONCOL

138 ×1.8

PRM

29 ×0.6

CR

22 ×0.5

PFM

40 ×1.0

IMMUN

Citations per year, relative to Barbara Ingold Heppner Barbara Ingold Heppner (= 1×) peers David Vicente Baz

Countries citing papers authored by Barbara Ingold Heppner

Since Specialization

Citations

This map shows the geographic impact of Barbara Ingold Heppner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbara Ingold Heppner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbara Ingold Heppner more than expected).

Fields of papers citing papers by Barbara Ingold Heppner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barbara Ingold Heppner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbara Ingold Heppner. The network helps show where Barbara Ingold Heppner may publish in the future.

Co-authorship network of co-authors of Barbara Ingold Heppner

This figure shows the co-authorship network connecting the top 25 collaborators of Barbara Ingold Heppner. A scholar is included among the top collaborators of Barbara Ingold Heppner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barbara Ingold Heppner. Barbara Ingold Heppner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Noske, Aurelia, Volker Möbus, Karsten E. Weber, et al.. (2019). Relevance of tumour-infiltrating lymphocytes, PD-1 and PD-L1 in patients with high-risk, nodal-metastasised breast cancer of the German Adjuvant Intergroup Node–positive study. European Journal of Cancer. 114. 76–88. 35 indexed citations

2.

Denkert, Carsten, G von Minckwitz, Silvia Darb‐Esfahani, et al.. (2017). Abstract S1-09: Evaluation of tumor-infiltrating lymphocytes (TILs) as predictive and prognostic biomarker in different subtypes of breast cancer treated with neoadjuvant therapy - A metaanalysis of 3771 patients. Cancer Research. 77(4_Supplement). S1–9. 21 indexed citations

3.

Schneeweiß, Andreas, Volker Moebus, Hans Tesch, et al.. (2017). A randomised phase III trial comparing two dose-dense, dose-intensified approaches (EPC and PM(Cb)) for neoadjuvant treatment of patients with high-risk early breast cancer (GeparOcto).. Journal of Clinical Oncology. 35(15_suppl). 518–518. 11 indexed citations

4.

Heppner, Barbara Ingold, Sibylle Loibl, & Carsten Denkert. (2016). Tumor-Infiltrating Lymphocytes: A Promising Biomarker in Breast Cancer. Breast Care. 11(2). 96–100. 29 indexed citations

5.

Denkert, Carsten, Berit M. Pfitzner, Barbara Ingold Heppner, & Manfred Dietel. (2015). Molekulare Pathologie beim Mammakarzinom. Der Pathologe. 36(2). 145–153. 6 indexed citations

6.

Heppner, Barbara Ingold, Katharina Balschun, Jochen Haag, et al.. (2014). HER2/neu testing in primary colorectal carcinoma. British Journal of Cancer. 111(10). 1977–1984. 127 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact